Topics:
Pediatric Oncology • Medical Oncology • Cardiology • Cardio-Oncology • Advanced Heart Failure and Transplant
Can CAR T cell therapy be considered for heart transplant recipients with concurrent lymphoproliferative disorders?
Answer from: at Academic Institution
The short version of my answer is: Possibly Yes. There is a very limited evidence from the literature in this topic, however, I will base my explanation on the following case reports: McKenna et l., PMID 37129856, Dang et al., PMID 33002249, Portuguese et al., PMID 36575360.The provided case re...
Sign in or Register to read more